-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Selected for the Province’s Second Batch of Advanced-Level Smart Factory List for 2025
Category:
发布时间：2025-10-21
【概要描述】
Recently, the Hebei Provincial Department of Industry and Information Technology announced the second batch of advanced-level smart factory designations for 2025, with the “Hebei Guangxiang Pharmaceutical Co., Ltd. Smart Factory” project of Shijiazhuang Sihua Pharmaceutical Group’s Hebei Guangxiang Pharmaceutical Co., Ltd. selected as one of the recipients.
Recently, the Hebei Provincial Department of Industry and Information Technology announced the second batch of advanced-level smart factory designations for 2025, with the “Hebei Guangxiang Pharmaceutical Co., Ltd. Smart Factory” project of Shijiazhuang Sihua Pharmaceutical Group’s Hebei Guangxiang Pharmaceutical Co., Ltd. being selected.
According to reports, a smart factory is centered on digital, networked, and intelligent technologies, achieving deep integration of advanced technologies such as the Internet of Things, big data, and artificial intelligence with production and manufacturing processes. This enables automated production, intelligent management, and data-driven decision-making. As a benchmark for intelligent manufacturing, smart factories not only provide technological demonstrations and best practices for upstream and downstream enterprises, thereby driving the intelligent upgrade of the industrial chain, but also accelerate the move of industrial clusters toward higher value-added segments and enhance the overall competitiveness of regional industries. The designation of advanced-level smart factories is conferred through a multi-stage process that includes enterprise application, review and recommendation by the municipal bureau of industry and information technology, expert evaluation organized by the provincial bureau of industry and information technology, and public announcement.
In recent years, Guangxiang Pharmaceutical has actively advanced its informationization and digital transformation by building a fully automated, intelligent industrial management platform for active pharmaceutical ingredients. This platform integrates process control, data acquisition, and automated control systems, thereby achieving systematic, integrated, automated, and intelligent manufacturing processes. Grounded in API production, the company has deployed a hyper-converged server cloud platform, a digital safety-production platform, an ERP system, and a collaborative office system, creating a secure and efficient data center. On the manufacturing side, leveraging an intelligent DCS system to analyze data in real time enables “one-click” control across the entire production process for multiple products, including caffeine. At the same time, big-data analytics are used to monitor market trends, while IoT technologies are employed to track equipment performance, enabling refined operations and driving cost reduction and efficiency gains. In addition, Guangxiang Pharmaceutical has established an information-based safety-production management platform that incorporates dual-control mechanisms and work permit systems into a unified management framework, effectively elevating its overall safety-management capabilities.
Currently, Guangxiang Pharmaceutical has obtained numerous international certifications, including CEP, BRC, FSSC 22000, PMDA, KOSHER, and HALAL. Its advanced intelligent manufacturing capabilities have effectively bolstered market development, facilitated stable partnerships with leading global customers, and driven substantial progress in the company’s growth.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091